GNW · Genworth Financial Inc
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
AI Brief
Q2 FY26 earnings call · Aug 6, 2026TL;DR. Genworth reported Q2 net income of $47M and adjusted operating income excluding Closed Block of $112M, raised 2026 Enact capital-return guidance to $445–$485M and share-repurchase guidance to $225–$250M, but Closed Block swung to a $110M adjusted operating loss driven by a $127M pre-tax A/E remeasurement loss with full-year A/E trending above the prior ~$300M expectation.
- + Raised 2026 expected capital returns from Enact to $445–$485M (from 81% ownership).
- + Raised 2026 share repurchase guidance to $225–$250M and repurchased $62M of shares at an average price of $8.74 in the quarter.
- + Enact primary new insurance written of $15 billion was up 15% year-over-year and primary insurance in-force grew 2% to $274B.
- − Closed Block adjusted operating loss of $110M driven by a $127M pre-tax LTC A/E remeasurement loss, with first-half A/E trending above the full-year ~$300M expectation.
- − GLIC consolidated RBC ratio fell to 286% from 289% in the prior quarter and 304% a year earlier, primarily from LTC losses including higher required capital on claims.
- − CareScout Services match volumes are currently pacing below the level required to reach the full-year target of approximately 7,500 matches versus 3,255 in 2025.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted operating income (loss), excluding Closed Block per share - Basic non-GAAP | $0.29 | Three months ended June 30, 2026 filing | — |
| Adjusted operating income (loss), excluding Closed Block per share - Diluted non-GAAP | $0.29 | Three months ended June 30, 2026 filing | — |
| Average invested assets and cash | $63.6B | Three months ended June 30, 2026 filing | — |
| Corporate and Other adjusted operating income (loss) non-GAAP | -$31M | Three months ended June 30, 2026 filing | — |
| Enact segment adjusted operating income (loss) non-GAAP | $143M | Three months ended June 30, 2026 filing | — |
| Gross incremental premiums approved | $46M | Three months ended June 30, 2026 filing | — |
| Impacted in-force premiums | $189M | Three months ended June 30, 2026 filing | — |
| New insurance written | $15.2B | the second quarter of 2026 filing | — |
| Primary persistency rate | 80% | the second quarter of 2026 filing | — |
| Weighted-average percentage rate increase approved | 24% | Three months ended June 30, 2026 filing | — |
| Adjusted operating income (loss), excluding Closed Block non-GAAP | 112M | Q2 2026 | — |
| Adjusted operating income (loss), excluding Closed Block per diluted share non-GAAP | $0.29 | Q2 2026 | — |
| Available Assets Above PMIERs Requirements | $1.89B | 2Q | — |
| CareScout matches | 1,459 | Q2 2026 | — |
| Direct Primary New Insurance Written | $15.2B | 2Q | — |
| Direct Primary Risk In-Force | $71.62B | 2Q | — |
| GLIC consolidated RBC ratio | 286% | Q2 2026 | — |
| Loss Ratio | 14% | 2Q | — |
| LTC MYRAP estimated net present value achieved since 2012 from IFAs | 34.8B | since 2012 through Q2 2026 | — |
| New Delinquencies | 12,299 | 2Q | — |
| Paid Claims | 361 | 2Q | — |
| PMIERs sufficiency ratio | 161% | Q2 2026 | — |
| Primary Cures | 12,278 | 2Q | — |
| Primary Delinquencies | 24,330 | 2Q | — |
| Primary insurance in-force | 274B | Q2 2026 | — |
| Primary new insurance written | 15.2B | Q2 2026 | — |
| Share repurchases | 62M | Q2 2026 | — |
| Share repurchases since program inception | 918M | since program inception through June 30, 2026 | — |
| Total Reserves | $599M | 2Q | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance - Life — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GNW
this stock
Genworth Financial Inc
|
$3.56B | +6.2% | +0.1% | 17.8 | 2.6% |
|
CILJF
China Life Insurance Co Ltd
|
$107.41B | +1.7% | — | — | 0.0% |
|
MFC
Manulife Financial Corp
|
$72.67B | +18.4% | — | — | 0.5% |
|
MET
Metlife Inc
|
$62.09B | +22.7% | +8.6% | 18.7 | 1.9% |
|
GWLIF
Great-West Lifeco Inc.
|
$59.05B | +26.6% | — | — | 0.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GNW | +2.2% | -7.3% | +11.5% | +6.9% | +6.2% |
| SPY | +1.2% | +0.6% | +11.6% | +1.6% | +13.6% |
| vs SPY | +1.0% | -7.9% | -0.1% | +5.3% | -7.4% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.